Notice of AGM and Annual Report

RNS Number : 6079Y

Ergomed plc

14 May 2021

 

 PRESS RELEASE

Notice of AGM and Annual Report

Guildford, UK - 14 May 2021 : Ergomed plc (LSE: ERGO) ("Ergomed" or the "Company"), a company focused on providing specialised services to the pharmaceutical industry, announces that its Annual General Meeting ("AGM") will be held at 80 Coleman Street, London, EC2R 6PA at 9:30 a.m. on Thursday, 10 June 2021. In light of the UK government's current COVID-19 measures, it is expected that the AGM will be run as a closed meeting and shareholders will not be able to attend in person.

Ergomed's Annual Report and Accounts for the year ended 31 December 2020, Notice of AGM and Form of Proxy will be available on the Company's website at www.ergomedplc.com and are being mailed to its shareholders today.

ENDS

Enquiries:

Ergomed plc	Tel: [phone]
Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited	Tel: [phone]
Freddie Barnfield / Matthew O'Dowd (Nominated Adviser)
James Black (Broker)
Consilium Strategic Communications	Tel: [phone]
Chris Gardner / Matthew Neal	[e-mail]
Angela Gray

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO). For further information, visit: http://ergomedplc.com .

 

END

 

 

NOADKNBKDBKBKPD